NASDAQ: CLBT
Cellebrite DI Ltd Stock

$18.06+0.22 (+1.23%)
Updated Jan 5, 2026
CLBT Price
$18.06
Fair Value Price
$5.87
Market Cap
$4.34B
52 Week Low
$13.10
52 Week High
$26.30
P/E
47.53x
P/B
9.7x
P/S
9.9x
PEG
1.87x
Dividend Yield
N/A
Revenue
$455.90M
Earnings
$76.33M
Gross Margin
84%
Operating Margin
13.47%
Profit Margin
16.7%
Debt to Equity
0.86
Operating Cash Flow
$153M
Beta
0.88
Next Earnings
Feb 19, 2026
Ex-Dividend
N/A
Next Dividend
N/A

CLBT Overview

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation. The company's Universal Forensic Extraction Device solution addresses problems in accessing digital information, including complicated device locks, encryption barriers, deleted and unknown content, and other obstacles that can prevent critical evidence from coming to light. It also offers Seeker solution that provides the ability to analyze video footage; OSINT Analyze, a real-time deep dive solution used to analyze open-source information, such as the surface web, deep web, and the dark web; and Crypto Tracer, which analyzes blockchain transactions together with related data from an extensive list of sources to identify and categorize wallets, and transactions. The company serves federal and state and local agencies, as well as enterprise companies and service providers. It has operations in the United States, Germany, Singapore, Australia, Brazil, United Kingdom, France, Canada, Japan, and India. The company was incorporated in 1999 and is based in Petah Tikva, Israel. Cellebrite Mobile Synchronization Ltd. operates as a subsidiary of Sun Corporation.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine CLBT's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Software Infrastructure

Industry Rating
B
CLBT
Ranked
#88 of 124

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$28.28A
$27.11A
$23.05A
View Top Software Infrastructure Stocks

Be the first to know about important CLBT news, forecast changes, insider trades & much more!

CLBT News

Overview

Due Diligence Score

Industry Average (32)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CLBT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CLBT ($18.06) is overvalued by 207.84% relative to our estimate of its Fair Value price of $5.87 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CLBT ($18.06) is not significantly undervalued (207.84%) relative to our estimate of its Fair Value price of $5.87 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CLBT ($18.06) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CLBT due diligence checks available for Premium users.

Valuation

CLBT fair value

Fair Value of CLBT stock based on Discounted Cash Flow (DCF)

Price
$18.06
Fair Value
$5.87
Overvalued by
207.84%
CLBT ($18.06) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CLBT ($18.06) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CLBT ($18.06) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CLBT price to earnings (PE)

For valuing profitable companies with steady earnings

Company
47.53x
Industry
31.01x
Market
44.68x
CLBT is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CLBT is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

CLBT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
9.7x
Industry
9.94x
CLBT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CLBT price to earnings growth (PEG)

For valuing profitable companies with growth potential

CLBT is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

CLBT's financial health

Profit margin

Revenue
$126.0M
Net Income
$20.2M
Profit Margin
16%
CLBT's Earnings (EBIT) of $61.40M... subscribe to Premium to read more.
Interest Coverage Financials
CLBT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$834.3M
Liabilities
$386.6M
Debt to equity
0.86
CLBT's short-term assets ($668.40M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CLBT's short-term assets ($668.40M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CLBT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CLBT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$33.3M
Investing
$63.8M
Financing
$5.3M
CLBT's operating cash flow ($152.70M)... subscribe to Premium to read more.
Debt Coverage Financials

CLBT vs Software Infrastructure Stocks

TickerZen RatingMarket Cap1d %P/EP/B
CLBTC$4.34B+1.23%47.53x9.70x
STNEC$4.34B+3.27%-25.98x1.99x
DLOB$4.34B+4.98%24.62x8.60x
OSC$4.48B+3.78%-39.98x9.50x
BOXC$4.09B-1.01%21.95x-14.26x

Cellebrite DI Stock FAQ

What is Cellebrite DI's quote symbol?

(NASDAQ: CLBT) Cellebrite DI trades on the NASDAQ under the ticker symbol CLBT. Cellebrite DI stock quotes can also be displayed as NASDAQ: CLBT.

If you're new to stock investing, here's how to buy Cellebrite DI stock.

What is the 52 week high and low for Cellebrite DI (NASDAQ: CLBT)?

(NASDAQ: CLBT) Cellebrite DI's 52-week high was $26.30, and its 52-week low was $13.10. It is currently -31.33% from its 52-week high and 37.86% from its 52-week low.

How much is Cellebrite DI stock worth today?

(NASDAQ: CLBT) Cellebrite DI currently has 240,358,573 outstanding shares. With Cellebrite DI stock trading at $18.06 per share, the total value of Cellebrite DI stock (market capitalization) is $4.34B.

Cellebrite DI stock was originally listed at a price of $10.07 in Sep 11, 2020. If you had invested in Cellebrite DI stock at $10.07, your return over the last 5 years would have been 79.34%, for an annualized return of 12.39% (not including any dividends or dividend reinvestments).

How much is Cellebrite DI's stock price per share?

(NASDAQ: CLBT) Cellebrite DI stock price per share is $18.06 today (as of Jan 5, 2026).

What is Cellebrite DI's Market Cap?

(NASDAQ: CLBT) Cellebrite DI's market cap is $4.34B, as of Jan 6, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Cellebrite DI's market cap is calculated by multiplying CLBT's current stock price of $18.06 by CLBT's total outstanding shares of 240,358,573.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.